Creso Pharma Limited: Company Update
(firmenpresse) -
Company Update
Creso Pharma Limited (ASX: CPH, the Company or Creso) is pleased to advise that regulatory approval from ASX for the shareholder meeting document to approve the transaction with Kunna Canada Ltd (Kunna Acquisition) has now been received.
Enclosed is a Notice of Meeting for a shareholders meeting to beheld on 16th October 2018 at 10:00am (WST).
Subject to the receipt of shareholder approval, Creso anticipates completing the Kunna Acquisition in mid-October 2018 and thereafter immediately advancing is business plan in Colombia.
Since first executing the agreement relating to the Kunna Acquisition, Colombia has cemented its place as the international jurisdiction of choice for low cost, high quality cannabis production. There have been multiple international (mainly Canadian) companies that have announced transactions to enter Colombia, including from the worlds largest cannabis company Canopy Growth Corp in a transaction worth up to US$96 million.
These transactions have vindicated Cresos move into Colombia and should provide investors with additional comfort in relation to Cresos strategy.
Creso further notes that, on 31 July 2018, Cresos Quarterly Activities Report stated that that the Company had completed the Kunna Acquisition. The Company intended for this to disclose that due diligence had been completed in relation to the Kunna Acquisition. Completion has not occurred and these statements are hereby retracted by Creso. As noted above, completion is now anticipated to occur in mid-October 2018 (subject to the receipt of shareholder approval).
Corporate Queries: -
EverBlu Capital
Level 39, Aurora Place
88 Phillip Street, Sydney, NSW 2000
E: info(at)everblucapital.com
P: +61 2 8249 0000
Leseranfragen:
" alt="Blox Labs Inc. and Cannvas MedTech Inc. Sign LOI for CannaBLOX Data AnalyticsDatum: 11.09.2018 - 14:19 Uhr
Sprache: Deutsch
News-ID 580834
Anzahl Zeichen: 1916
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 247 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Creso Pharma Limited: Company Update
"
steht unter der journalistisch-redaktionellen Verantwortung von
Creso Pharma Limited (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
